# Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome

> **NCT00128180** · PHASE2 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 66 (actual)

## Conditions studied

- Hantavirus Infections

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00128180
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2010-12
- **Final completion:** 2011-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2014-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128180, "Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00128180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*